CRGY

Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Total revenue 744.87 M875.29 M950.17 M897.98 M866.58 M865.05 M 3.58 B Gross profit 744.87 M875.29 M950.17 M897.98 M866.58 M865.05 M 3.58 B Operating expenses 752.3 M902.81 M777.95 M818.35 M835.78 M918.43 M 3.35 B Selling/general/admin expenses 159.68 M86.69 M56.77 M124.61 M74.28 M216.5 M 472.16 M Research & development —————— — Operating income 7.42 M-42.36 M172.23 M79.64 M30.8 M-53.38 M 229.28 M Non-Operating Income, Total 203 K178.77 M163.7 M123.92 M45.1 M-305.12 M 27.61 M Interest expense, net of interest capitalized 61.84 M69.38 M73.18 M75.22 M72.63 M77.4 M 298.43 M Non-Operating Income, excl. Interest Expenses -63.27 M110.04 M90.41 M48.59 M-27.74 M-377.06 M -265.81 M Unusual income/expense 1.63 M-645 K115 K115 K209 K-5.46 M -5.02 M Pretax income 7.22 M43.23 M8.52 M203.56 M14.3 M-24.71 M 201.67 M Equity in earnings 44 K509 K392 K439 K864 K493 K 2.19 M Taxes 1.6 M13.77 M2.6 M41.1 M4 M-5.13 M 42.57 M Non-controlling/minority interest 5.9 M-34.31 M8.06 M9.28 M762 K16.16 M 34.26 M After tax other income/expense —————— — Net income before discontinued operations 9.95 M42.95 M2.15 M153.22 M9.51 M-31.97 M 132.91 M Discontinued operations —————— — Net income 9.95 M42.95 M2.15 M153.22 M9.51 M-31.97 M 132.91 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 9.95 M42.95 M2.15 M153.22 M9.51 M-31.97 M 132.91 M Basic earnings per share (Basic EPS) -0.07-0.9-0.010.61-0.04-0.01 0.55 Diluted earnings per share (Diluted EPS) -0.07-0.89-0.010.6-0.04-0.01 0.54 Average basic shares outstanding 146.62 M130.72 M191.29 M253.17 M254.62 M242.06 M 941.15 M Diluted shares outstanding 146.62 M130.72 M191.29 M255.45 M254.62 M245.06 M 946.42 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 251.5 M309.04 M282.57 M297.06 M298.45 M288.82 M 1.17 B